Rana Therapeutics, Inc.

Calculating rank

USPTO Granted Patents = 4

Trademarks = 1

Forward Citations = 66

Loading Chart...

13 inventors (with patents filed for the assignee):

Frank DeRosa (3 out of 146 patents)

Michael W Heartlein (3 out of 189 patents)

Braydon Charles Guild (2 out of 61 patents)

4. Shrirang Karve (1 out of 71 patents)

5. Romesh R Subramanian (1 out of 77 patents)

6. Christian Plank (1 out of 15 patents)

7. Carsten Rudolph (1 out of 27 patents)

8. Jerry Chi Zhang (1 out of 5 patents)

9. Lianne Smith (1 out of 13 patents)

10. Markus Weber (1 out of 6 patents)

11. Thomas Dino Rockel (1 out of 5 patents)

12. Eugen Uhlmann (1 out of 80 patents)

13. Arthur Mertz Krieg (1 out of 69 patents)

4 patents: Sort by Forward Citations

1. 9717690 - Cleavable lipids (2017-08-01),

2. 9713626 - CFTR mRNA compositions and related methods and uses (2017-07-25),

3. 9668980 - Encapsulation of messenger RNA (2017-06-06),

4. 9580708 - Multimeric oligonucleotides compounds (2017-02-28),

Company Overview

Rana Therapeutics, Inc. is a biotechnology company that focuses on developing RNA-targeted therapeutics for the treatment of various diseases. They leverage their proprietary technology platform to design and optimize RNA-targeting compounds that have the potential to treat a wide range of conditions. Through innovative research and development efforts, Rana Therapeutics is dedicated to advancing the field of RNA-based therapies to improve patient outcomes.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

4 Patents

#98 in Lexington, MA

#3,316 in Massachusetts

#60,704 in US

Lexington, MA, United States of America